ESR Essentials: artificial intelligence in breast imaging—practice recommendations by the European Society of Breast Imaging - Top-Institutions - MDSpire

ESR Essentials: artificial intelligence in breast imaging—practice recommendations by the European Society of Breast Imaging

  • By

  • Simone Schiaffino

  • Daniela Bernardi

  • Nuala Healy

  • Maria Adele Marino

  • Valeria Romeo

  • Ioannis Sechopoulos

  • Ritse M. Mann

  • Katja Pinker

  • August 26, 2025

  • 0 min

Share

Top Institutions in Radiology

Brief introduction explaining scope and methodology.

  • #1

    Memorial Sloan Kettering Cancer Center
    Memorial Sloan Kettering Cancer Center

    New York, NY

    Key Differentiators

    • Breast Imaging
    • Radiology
    • Artificial Intelligence in Medicine

  • #2

    Massachusetts General Hospital
    Massachusetts General Hospital

    Boston, MA

    Key Differentiators

    • Breast Imaging
    • Radiology
    • Medical AI Research

  • #3

    The Royal Marsden NHS Foundation Trust
    The Royal Marsden NHS Foundation Trust

    London, England

    Key Differentiators

    • Breast Imaging
    • Oncology
    • AI in Medical Imaging

  • #4

    Stanford University Medical Center
    Stanford University Medical Center

    Stanford, CA

    Key Differentiators

    • Radiology
    • Breast Imaging
    • Artificial Intelligence

  • #5

    University of Cambridge
    University of Cambridge

    Cambridge, England

    Key Differentiators

    • Breast Imaging
    • Medical AI
    • Radiology

Original Source(s)

ESR Essentials: artificial intelligence in breast imaging—practice recommendations by the European Society of Breast Imaging

  • by Simone Schiaffino, Daniela Bernardi, Nuala Healy, Maria Adele Marino, Valeria Romeo, Ioannis Sechopoulos, Ritse M. Mann, Katja Pinker

  • August 26, 2025

Related Content

Images in Vascular Medicine: Multimodal imaging of adventitial cystic disease of the superficial femoral artery

FDA Cleared ≠ FDA Validated

Most AI medical devices reach the market without independent evidence of safety or effectiveness.

A Deep Learning Breast Cancer Risk Model for Precise Supplemental Screening